These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neuroactive steroids in depression and anxiety disorders: clinical studies. Eser D; Schüle C; Baghai TC; Romeo E; Rupprecht R Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334 [TBL] [Abstract][Full Text] [Related]
5. Effects on gamma-aminobutyric acid (GABA)(A) receptors of a neuroactive steroid that negatively modulates glutamate neurotransmission and augments GABA neurotransmission. Mennerick S; Zeng CM; Benz A; Shen W; Izumi Y; Evers AS; Covey DF; Zorumski CF Mol Pharmacol; 2001 Oct; 60(4):732-41. PubMed ID: 11562435 [TBL] [Abstract][Full Text] [Related]
6. The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Strous RD; Maayan R; Weizman A Eur Neuropsychopharmacol; 2006 Apr; 16(3):155-69. PubMed ID: 16257183 [TBL] [Abstract][Full Text] [Related]
7. [Metabotropic glutamate receptors: new molecular targets in the treatment of neurological and psychiatric diseases]. Luján-Miras R Rev Neurol; 2005 Jan 1-15; 40(1):43-53. PubMed ID: 15696426 [TBL] [Abstract][Full Text] [Related]
8. Neuroactive steroids as modulators of depression and anxiety. Eser D; Romeo E; Baghai TC; di Michele F; Schüle C; Pasini A; Zwanzger P; Padberg F; Rupprecht R Neuroscience; 2006; 138(3):1041-8. PubMed ID: 16310959 [TBL] [Abstract][Full Text] [Related]
9. Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Gasior M; Carter RB; Witkin JM Trends Pharmacol Sci; 1999 Mar; 20(3):107-12. PubMed ID: 10203866 [TBL] [Abstract][Full Text] [Related]
10. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Zheng P Prog Neurobiol; 2009 Oct; 89(2):134-52. PubMed ID: 19595736 [TBL] [Abstract][Full Text] [Related]